GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cantargia AB (OSTO:CANTA) » Definitions » Market Cap

Cantargia AB (OSTO:CANTA) Market Cap : kr824.39 Mil (As of Jun. 07, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Cantargia AB Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cantargia AB's share price for the quarter that ended in Mar. 2024 was kr3.49. Cantargia AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 183.69 Mil. Therefore, Cantargia AB's market cap for the quarter that ended in Mar. 2024 was kr641.07 Mil.

Cantargia AB's quarterly market cap declined from Sep. 2023 (kr711.37 Mil) to Dec. 2023 (kr686.62 Mil) and declined from Dec. 2023 (kr686.62 Mil) to Mar. 2024 (kr641.07 Mil).

Cantargia AB's annual market cap declined from Dec. 2021 (kr1,849.56 Mil) to Dec. 2022 (kr514.32 Mil) but then increased from Dec. 2022 (kr514.32 Mil) to Dec. 2023 (kr686.62 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cantargia AB's Enterprise Value for Today is kr681.78 Mil.


Cantargia AB Market Cap Historical Data

The historical data trend for Cantargia AB's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantargia AB Market Cap Chart

Cantargia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,467.01 6,412.32 1,849.56 514.32 686.62

Cantargia AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,131.34 681.31 711.37 686.62 641.07

Competitive Comparison of Cantargia AB's Market Cap

For the Biotechnology subindustry, Cantargia AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantargia AB's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cantargia AB's Market Cap distribution charts can be found below:

* The bar in red indicates where Cantargia AB's Market Cap falls into.



Cantargia AB Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Cantargia AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=kr3.738*183.687
=kr686.62

Cantargia AB's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=kr3.49*183.687
=kr641.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cantargia AB  (OSTO:CANTA) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Cantargia AB Market Cap Related Terms

Thank you for viewing the detailed overview of Cantargia AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantargia AB (OSTO:CANTA) Business Description

Traded in Other Exchanges
Address
Scheelevagen 27, Lund, SWE, SE-223 63
Cantargia AB is engaged in the development of products used in the treatment of cancer. It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's first product candidate, CAN04, has also been designed to treat different forms of cancer, with the initial focus on the treatment of non-small cell lung cancer and pancreatic cancer. The CAN10 project covers a disease segment that complements nadunolimab and diversifies Cantargia's project portfolio.

Cantargia AB (OSTO:CANTA) Headlines

No Headlines